TNF and tuberculosis: Active and continuous surveillance for tuberculosis in patients treated mainly with anti-TNF drugs is mandatory, especially in countries with high rates of the disease or in individuals living in endemic areas.26, 106, 107 Routine tests should preferably be requested every two to five months during follow-up (Table 3).